Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Reviews in Endocrine & Metabolic Disorders|May 27, 2024
Progress, challenges and perspectives in the management of hypopituitarismCesar Luiz Boguszewski, Sebastian Neggers
European Endocrinology|October 24, 2018
Extra-hepatic AcromegalySanne E Franck, Aart Jan van der Lely, Sebastian Neggers
Journal of Neuroendocrinology|March 22, 2026
DNA methylation as a predictor of pituitary neuroendocrine tumour behaviour: A systematic reviewRomy van der Groef, Eskeatnaf Mulugeta, Sebastian Neggers, et al.
Advances in Therapy|January 12, 2021
Patient and Healthcare Provider Perspectives of First-Generation Somatostatin Analogs in the Management of Neuroendocrine Tumors and Acromegaly: A Systematic Literature ReviewDavid Cella, Jennifer Evans, Marion Feuilly, et al.
European Journal of Endocrinology|April 17, 2026
Molecular Imaging in Pituitary Neuroendocrine Tumors: A Narrative Review of Advances, Challenges, and Future PerspectivesRomy van der Groef, Ilanah Pruis, Amber Audhoe, et al.
Leukemia Research|January 15, 2013
Endocrine sequelae and metabolic syndrome in adult long-term survivors of childhood acute myeloid leukemiaKarin Blijdorp, Marjolein van Waas, Aart-Jan van der Lely, et al.
European Journal of Endocrinology|December 15, 2010
Coadministration of lanreotide Autogel and pegvisomant normalizes IGF1 levels and is well tolerated in patients with acromegaly partially controlled by somatostatin analogs aloneAart-Jan van der Lely, Ignacio Bernabeu, Jan Cap, et al.
Pediatric Blood & Cancer|December 14, 2011
The limited screening value of insulin-like growth factor-I as a marker for alterations in body composition in very long-term adult survivors of childhood cancerKarin Blijdorp, Marry van den Heuvel-Eibrink, Rob Pieters, et al.
The Journal of Biological Chemistry|March 28, 2021
A novel peptide antagonist of the human growth hormone receptorReetobrata Basu, Khairun Nahar, Prateek Kulkarni, et al.
Pituitary|January 1, 2022
Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United StatesMaria Fleseriu, Ariel Barkan, Maria Del Pilar Schneider, et al.
Pageof 4